Power Law company profile

Carmot Therapeutics

Biotech & Life Sciences · San Francisco, United States · Founded 2008 Unicorn

Dedicated to the discovery and development of innovative medicines

Valuation

$2.5–5B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

13 investors on Carmot Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 13 investors entered at this stage

TCGX

Venrock Healthcare Capital Partners

The Column Group

Janus Henderson Investors

Millennium Management

Frazier Healthcare Partners

Franklin Templeton Investments

Willett Advisors

Deep Track Capital

Amgen

Horizons Ventures

RA Capital Management

5AM Ventures

Global footprint

Where Carmot Therapeutics has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Web traffic by country

380 monthly visits
across markets

🇺🇸 United States105.3%

Top 1 markets shown

Patent intelligence

$6M patent portfolio · 22 active families

Estimated portfolio value

$6M

0.21% of valuation · 483.2× smaller than top peer Illumina ($2.7B)

22 active patent families

Where Carmot Therapeutics innovates AgonistPharmacologyPeptidePharmaceutical SubstancesMedicinal chemistry

Where Carmot Therapeutics concentrates vs peers

Each axis is a top-10 topic across Carmot Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Carmot Therapeutics

An AI-synthesized read of the highest-engagement posts about Carmot Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Carmot Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles